The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
First trimester trophoblast cells secrete Fas ligand which induces immune cell apoptosis
Abstract
Since the invading trophoblast represents a semi-allograft, it should be rejected by the mother. It has, therefore, been postulated that during normal pregnancy the trophoblast evades the maternal immune system though the establishment of immune privilege by triggering the death of activated lymphocytes which may be sensitized to paternal alloantigens. Such peripheral tolerance may be directed through the Fas/Fas ligand (FasL) apoptotic pathway and mediated by FasL expressed by the trophoblast. However, in vivo studies show that membrane-associated expression of FasL may instead promote allograft rejection, rather than protection. The aim of this study was to determine if there is a role for FasL in trophoblast immune privilege. In this study, we demonstrate that isolated first trimester trophoblast cells lack membrane-associated FasL, but express a cytoplasmic form in association with a specialized secretory lysosomal pathway. Furthermore, this intracellular FasL is constitutively secreted by trophoblast cells via the release of microvesicles. Following disruption of these microvesicles, the whole 37 kDa secreted FasL is able to induce T-cell death by apoptosis through activation of the Fas pathway. Therefore, we propose that secretion of FasL may be one mechanism by which trophoblast cells promote a state of immune privilege and, therefore, protect themselves from maternal immune recognition.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prevention of Allogeneic Fetal Rejection by Tryptophan Catabolism
Munn, D. H., Zhou, M., Attwood, J. T., Bondarev, I., Conway, S. J., Marshall, B., Brown, C., & Mellor, A. L. (1998) · Science · doi:10.1126/science.281.5380.1191 · Cited by 2,585
CD95's deadly mission in the immune system
Krammer, P. H. (2000) · Nature · doi:10.1038/35037728 · Cited by 1,717
Fas ligand mediates activation-induced cell death in human T lymphocytes.
Alderson, M. R., Tough, T. W., Davis-Smith, T., Braddy, S., Falk, B., Schooley, K. A., Goodwin, R. G., Smith, C. A., Ramsdell, F., & Lynch, D. H. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.1.71 · Cited by 934
Rapid Secretion of Interleukin-1β by Microvesicle Shedding
MacKenzie, A., Wilson, H. L., Kiss-Toth, E., Dower, S. K., North, R. A., & Surprenant, A. (2001) · Immunity · doi:10.1016/s1074-7613(01)00229-1 · Cited by 863
Medawar, P. B., & Medawar, P. B. (1953) · Symposia of the Society for Experimental Biology · Cited by 833
Metalloproteinase-mediated release of human Fas ligand.
Kayagaki, N., Kawasaki, A., Ebata, T., Ohmoto, H., Ikeda, S., Inoue, S., Yoshino, K., Okumura, K., & Yagita, H. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.6.1777 · Cited by 822
Induction of Lymphocyte Apoptosis by Tumor Cell Secretion of FasL-bearing Microvesicles
Andreola, G., Rivoltini, L., Castelli, C., Huber, V., Perego, P., Deho, P., Squarcina, P., Accornero, P., Lozupone, F., Lugini, L., et al. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20011624 · Cited by 774
T Cell Awareness of Paternal Alloantigens During Pregnancy
Tafuri, A., Alferink, J., Möller, P., Hämmerling, G. J., & Arnold, B. (1995) · Science · doi:10.1126/science.270.5236.630 · Cited by 572
Kang, S.-M., Schneider, D. B., Lin, Z., Hanahan, D., Dichek, D. A., Stock, P. G., & Baekkeskov, S. (1997) · Nature Medicine · doi:10.1038/nm0797-738 · Cited by 450
Bossi, G., & Griffiths, G. M. (1999) · Nature Medicine · doi:10.1038/4779 · Cited by 387
Regulation of the Proinflammatory Effects of Fas Ligand (CD95L)
Chen, J.-J., Sun, Y., & Nabel, G. J. (1998) · Science · doi:10.1126/science.282.5394.1714 · Cited by 383
Allison, J., Georgiou, H. M., Strasser, A., & Vaux, D. L. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.8.3943 · Cited by 366
Activated Human T Cells Release Bioactive Fas Ligand and APO2 Ligand in Microvesicles
Martínez-Lorenzo, M. J., Anel, A., Gamen, S., Monleón, I., Lasierra, P., Larrad, L., Piñeiro, A., Alava, M. A., & Naval, J. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.3.1274 · Cited by 307
Monleón, I., Martínez-Lorenzo, M. J., Monteagudo, L., Lasierra, P., Taulés, M., Iturralde, M., Piñeiro, A., Larrad, L., Alava, M. A., Naval, J., et al. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.12.6736 · Cited by 266
The role of FasL-induced apoptosis in immune privilege
Griffith, T. S., & Ferguson, T. A. (1997) · Immunology Today · doi:10.1016/s0167-5699(97)81663-5 · Cited by 253
Expression of Fas ligand in liver metastases of human colonic adenocarcinomas
Shiraki, K., Tsuji, N., Shioda, T., Isselbacher, K. J., & Takahashi, H. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.12.6420 · Cited by 252
Gene transfer of Fas ligand induces tumor regression in vivo
Arai, H., Gordon, D., Nabel, E. G., & Nabel, G. J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.25.13862 · Cited by 248
Hohlbaum, A. M., Moe, S., & Marshak-Rothstein, A. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.7.1209 · Cited by 241
Rabinowich, H., Reichert, T. E., Kashii, Y., Gastman, B. R., Bell, M. C., & Whiteside, T. L. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1518 · Cited by 235
Bechmann, I., Mor, G., Nilsen, J., Eliza, M., Nitsch, R., & Naftolin, F. (1999) · Glia · doi:10.1002/(sici)1098-1136(199907)27:1<62::aid-glia7>3.0.co;2-s · Cited by 225
Uckan, D. (1997) · Molecular Human Reproduction · doi:10.1093/molehr/3.8.655 · Cited by 206
Expression of Fas ligand by human cytotrophoblasts: implications in placentation and fetal survival
Runic, R. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.8.3119 · Cited by 197
Multiple mechanisms of peripheral T cell tolerance to the fetal "allograft".
Jiang, S., & Vacchio, M. S. (1998) · PubMed · Cited by 190
Differential Regulation and Function of the Fas/Fas Ligand System in Human Trophoblast Cells1
Aschkenazi, S., Straszewski, S., Verwer, K. M. A., Foellmer, H., Rutherford, T., & Mor, G. (2002) · Biology of Reproduction · doi:10.1095/biolreprod66.6.1853 · Cited by 161
Fas ligand is targeted to secretory lysosomes via a proline-rich domain in its cytoplasmic tail
Blott, E. J., Bossi, G., Clark, R., Zvelebil, M., & Griffiths, G. M. (2001) · Journal of Cell Science · doi:10.1242/jcs.114.13.2405 · Cited by 159
Epithelial ovarian cancer cells secrete functional Fas ligand.
Abrahams, V. M., Chavez, S. L., Kamsteeg, M., Hanczaruk, B., Schwartz, P. E., Rutherford, T., & Mor, G. (2003) · PubMed · Cited by 139
Self-citationAbrahams, V. M., Cambridge, G., Lydyard, P. M., & Edwards, J. (2000) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200003)43:3<608::aid-anr18>3.0.co;2-g · Cited by 131
Self-citationHolmes, C., Simpson, K. L., Wainwright, S., Tate, C., Houlihan, J., Sawyer, I. H., Rogers, I., Spring, F., Anstee, D., & Tanner, M. (1990) · Journal of Immunology · doi:10.4049/jimmunol.144.8.3099 · Cited by 130
Placental Fas Ligand Expression Is a Mechanism for Maternal Immune Tolerance to the Fetus
Kauma, S. W., Huff, T. F., Hayes, N., & Nilkaeo, A. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.6.5730 · Cited by 125
Fas‐Fas Ligand System‐Induced Apoptosis in Human Placenta and Gestational Trophoblastic Disease
Mor, G., Gutierrez, L. S., Eliza, M., KAHYAOGLU, F., & Arici, A. M. (1998) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.1998.tb00396.x · Cited by 117
Bamberger, A., Schulte, H. M., Thuneke, I., Erdmann, I., Bamberger, C. M., & Asa, S. L. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.9.4360 · Cited by 108
Yung, W.-L.-K., & King, A. (2000) · Bailliere's best practice & research. Clinical obstetrics & gynaecology · doi:10.1053/beog.2000.0122 · Cited by 90
Shudo, K., Ryu, I., & Shigekazu, N. (2003) · Kanazawa University Repository for Academic Resources (DSpace) (Kanazawa University) · Cited by 89
The Fas/Fas‐ligand system: a mechanism for immune evasion in human breast carcinomas
Gutierrez, L. S., Eliza, M., Niven‐Fairchild, T., Naftolin, F. N., & Mor, G. (1999) · Breast Cancer Research and Treatment · doi:10.1023/a:1006102601215 · Cited by 89
Mor, G., Kohen, F., García-Velasco, J. A., Nilsen, J., Brown, W., Song, J. H., & Naftolin, F. N. (2000) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(00)00081-9 · Cited by 88
Membrane Fas Ligand Activates Innate Immunity and Terminates Ocular Immune Privilege
Gregory, M. S., Repp, A. C., Hohlbaum, A. M., Saff, R. R., Marshak‐Rothstein, A., & Ksander, B. R. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.5.2727 · Cited by 84
Laminin in human trophoblast—decidua interaction
Loke, Y. W., Gardner, L., Burland, K., & King, A. (1989) · Human Reproduction · doi:10.1093/oxfordjournals.humrep.a136926 · Cited by 73
Expression of Fas-ligand in first trimester and term human placental villi
Hammer, A., & Dohr, G. (2000) · Journal of Reproductive Immunology · doi:10.1016/s0165-0378(99)00059-5 · Cited by 73
γδ T cells of human early pregnancy decidua: evidence for cytotoxic potency
Mincheva‐Nilsson, L., Nagaeva, O., Sundqvist, K., et al. (2000) · International Immunology · doi:10.1093/intimm/12.5.585 · Cited by 69
Neale, D. M., Demasio, K. A., Illuzzi, J. L., Chaiworapongsa, T., Romero, R. J., & Mor, G. (2003) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/jmf.13.1.39.44 · Cited by 64
Placental Fas Ligand Expression Is a Mechanism for Maternal Immune Tolerance to the Fetus
Kauma, S. W. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.6.2188 · Cited by 62
Ohshima, K., Nakashima, M., Sonoda, K., et al. (2001) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2001.01461.x · Cited by 57
Labor-Associated Changes in Fas Ligand Expression and Function in Human Placenta
Balkundi, D. R., Hanna, N. N., Hleb, M., Dougherty, J. J., & Sharma, S. (2000) · Pediatric Research · doi:10.1203/00006450-200003000-00004 · Cited by 46
Shed membrane fragment modulation of CD3-zeta during pregnancy: link with induction of apoptosis
Gerçel-Taylor, Ç., O’Connor, S., Lam, G. K., & Taylor, D. D. (2002) · Journal of Reproductive Immunology · doi:10.1016/s0165-0378(02)00025-6 · Cited by 42
A NON-CLEAVABLE MUTANT OF FAS LIGAND DOES NOT PREVENT NEUTROPHILIC DESTRUCTION OF ISLET TRANSPLANTS1
Kang, S., Braat, D., Schneider, D. B., O’Rourke, R. W., Lin, Z., Ascher, N. L., Dichek, D. A., Bækkeskov, S., & Stock, P. G. (2000) · Transplantation · doi:10.1097/00007890-200005150-00014 · Cited by 39
Hammer, A., & Dohr, G. (1999) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.1999.tb00471.x · Cited by 36
Mor, G., & Abrahams, V. M. (2002) · Immunology and Allergy Clinics of North America · doi:10.1016/s0889-8561(02)00009-7 · Cited by 36
Self-citationJodo, S., Hohlbaum, A. M., Xiao, S., Chan, D. V., Strehlow, D., Sherr, D. H., Marshak‐Rothstein, A., & Ju, S. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.10.5487 · Cited by 34
Fas-Fas ligand system induced apoptosis in human placenta and gestational trophoblastic disease
Mor, G., Gutierrez, L., Eliza, M., & Arici, A. M. (1998) · Journal of the Society for Gynecologic Investigation · doi:10.1016/s1071-5576(97)86131-x · Cited by 8
Cited by
Classification, Functions, and Clinical Relevance of Extracellular Vesicles
van der Pol, E., Böing, A. N., Harrison, P., Sturk, A., & Nieuwland, R. (2012) · Pharmacological Reviews · doi:10.1124/pr.112.005983 · Cited by 1,754
The unique immunological and microbial aspects of pregnancy
Mor, G., Aldo, P., & Alvero, A. B. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2017.64 · Cited by 1,041
Membrane Microparticles: Two Sides of the Coin
Hugel, B., Martínez, M. C., Kunzelmann, C., & Freyssinet, J.-M. (2005) · Physiology · doi:10.1152/physiol.00029.2004 · Cited by 698
Exosomes for drug delivery—A novel application for the mesenchymal stem cell
Lai, R. C., Yeo, R. W. Y., Tan, K. H., & Lim, S. K. (2013) · Biotechnology Advances · doi:10.1016/j.biotechadv.2012.08.008 · Cited by 546
Viral Infections During Pregnancy
Silasi, M., Cardenas, I., Kwon, J., Racicot, K., Aldo, P., & Mor, G. (2015) · American Journal of Reproductive Immunology · doi:10.1111/aji.12355 · Cited by 500
Metadata
- Authors
- Abrahams, V. M.
- Venue
- Molecular Human Reproduction
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-01-01
- Volume
- 10
- Issue
- 1
- Pages
- 55-63
- ISSN
- 1360-9947 (ISSN-L)
- 1460-2407
- OpenAlex
- W2130776611
- Cited by
- 254
- References
- 49
- FWCI
- 2.81
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.